Johnson, Bryan A.
Xie, Xuping http://orcid.org/0000-0003-0918-016X
Bailey, Adam L. http://orcid.org/0000-0002-6560-9680
Kalveram, Birte
Lokugamage, Kumari G.
Muruato, Antonio
Zou, Jing
Zhang, Xianwen
Juelich, Terry
Smith, Jennifer K.
Zhang, Lihong
Bopp, Nathen
Schindewolf, Craig http://orcid.org/0000-0002-9804-2246
Vu, Michelle
Vanderheiden, Abigail
Winkler, Emma S.
Swetnam, Daniele http://orcid.org/0000-0002-6694-5571
Plante, Jessica A. http://orcid.org/0000-0002-4768-7458
Aguilar, Patricia
Plante, Kenneth S. http://orcid.org/0000-0002-7485-3167
Popov, Vsevolod
Lee, Benhur http://orcid.org/0000-0003-0760-1709
Weaver, Scott C. http://orcid.org/0000-0001-8016-8556
Suthar, Mehul S.
Routh, Andrew L. http://orcid.org/0000-0002-2874-5990
Ren, Ping http://orcid.org/0000-0002-4022-6667
Ku, Zhiqiang
An, Zhiqiang http://orcid.org/0000-0001-9309-2335
Debbink, Kari
Diamond, Michael S.
Shi, Pei-Yong http://orcid.org/0000-0001-5553-1616
Freiberg, Alexander N.
Menachery, Vineet D. http://orcid.org/0000-0001-8803-7606
Article History
Received: 26 August 2020
Accepted: 13 January 2021
First Online: 25 January 2021
Competing interests
: X.X., P.-Y.S. and V.D.M. have filed a US patent on the reverse genetic system and SARS-CoV-2 reporter. M.S.D. is a consultant for Inbios, Vir Biotechnology and NGM Biopharmaceuticals, and is on the Scientific Advisory Board of Moderna and Immunome. The laboratory of M.S.D. has received unrelated funding support in sponsored research agreements from Moderna, Vir Biotechnology and Emergent BioSolutions. The other authors declare no competing interests.
Free to read: This content has been made available to all.